Edesa Biotech, Inc.EDSANASDAQ
Loading
Year-over-year earnings per share growth rate
3Y CAGR
-24.2%/yr
vs -19.5%/yr prior
Acceleration
-4.7pp
Decelerating
Percentile
P56
Within normal range
vs 3Y Ago
0.4x
Contraction
Streak
1 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q4 2025 | 12.50% |
| Q3 2025 | -28.00% |
| Q2 2025 | 16.67% |
| Q1 2025 | 37.50% |
| Q4 2024 | -60.00% |
| Q3 2024 | 42.31% |
| Q2 2024 | 10.34% |
| Q1 2024 | -7.41% |
| Q4 2023 | 5.26% |
| Q3 2023 | 16.18% |
| Q2 2023 | 17.07% |
| Q1 2023 | 5.75% |
| Q4 2022 | 28.69% |
| Q3 2022 | 53.26% |
| Q2 2022 | -12.99% |
| Q1 2022 | -0.43% |
| Q4 2021 | -17.95% |
| Q3 2021 | 22.31% |
| Q2 2021 | -84.56% |
| Q1 2021 | 24.44% |
| Q4 2020 | -19.21% |
| Q3 2020 | -7.86% |
| Q2 2020 | -17.65% |
| Q1 2020 | -16.67% |
| Q4 2019 | -15.91% |
| Q3 2019 | 58.10% |
| Q2 2019 | 83.91% |
| Q1 2019 | -17.78% |
| Q4 2018 | -772.44% |
| Q3 2018 | 91.94% |
| Q2 2018 | 58.31% |
| Q1 2018 | 3.45% |
| Q4 2017 | -703.90% |
| Q3 2017 | 86.22% |
| Q2 2017 | -10.37% |
| Q1 2017 | 25.69% |
| Q4 2016 | -668.09% |
| Q3 2016 | 86.50% |
| Q2 2016 | -38.68% |
| Q1 2016 | 47.65% |